-
Tesofensine Peptide Review: Benefits, Results, Dose, & More
18 Dec 2023 17:01 GMT
… to that of antidepressants.
Tesofensine is thought to … III trials.3
Phase II trials for Tesofensine in obese … with your doctor or other trusted medical or … Tesofensine, a monoamine reuptake inhibitor for the treatment of obesity. Curr Opin Investig Drugs …
-
Obesity Pipeline Analysis: Over 120 companies are working on improvements
09 Nov 2022 04:08 GMT
… Pharma, ERX Pharmaceuticals, Amgen, Allysta Pharmaceuticals, Empros Pharma, … , Midazolam, Tirzepatide, Tesofensine and others.
The … the drug’s mechanism of action, clinical trials, … in obesity treatment @ Obesity Pipeline Report
Obesity overview
Obesity can …
-
Saniona Provides Update On Ongoing Review Of Tesofensine In Mexico
20 May 2022 08:16 GMT
… of seeking approval for tesofensine in Mexico. For more … mid-stage clinical trials for hypothalamic obesity and Prader-Willi … a proprietary ion channel drug discovery engine anchored by … 1 clinical trial and is positioned for the treatment of neuropathic …
-
Saniona Updates Tesomet Clinical Development Timelines Based on Manufacturing Feedback from U.S. FDA
21 Apr 2021 23:00 GMT
… .S. Food and Drug Administration (FDA) regarding its proposed … fixed-dose combination of tesofensine (a triple monoamine … developing, and delivering innovative treatments for rare disease patients … mid-stage clinical trials for hypothalamic obesity and Prader- …
-
Saniona Announces Partnership with the Foundation for Prader-Willi Research (FPWR) to Support its Prader-Willi Syndrome (PWS) Clinical Trial with Tesomet
19 Apr 2021 12:00 GMT
… treatment of hypothalamic obesity (HO) and plans to begin a Phase 2b trial … mid-stage clinical trials for hypothalamic obesity and Prader- … dose combination therapy of tesofensine (a triple monoamine … . There are no medications approved specifically for the …
-
Saniona Announces Oral Presentation of Tesomet Data in Hypothalamic Obesity at ENDO 2021
15 Mar 2021 12:00 GMT
… 2 trial of Tesomet for the treatment of hypothalamic obesity with the medical community … clinical trials for the rare diseases Prader-Willi syndrome and hypothalamic obesity … fixed-dose combination therapy of tesofensine (a triple monoamine reuptake inhibitor …
-
Saniona Receives Feedback from U.S. FDA Providing a Regulatory Path Forward for Tesomet in Hypothalamic Obesity
08 Mar 2021 13:00 GMT
… an unmet medical need. The FDA indicated overall … Drug (IND) application and initiate its planned Phase 2b clinical trial … combination therapy of tesofensine (a triple monoamine … this treatment globally. About Hypothalamic Obesity (HO)
Hypothalamic obesity (HO …
-
Saniona Receives U.S. FDA Orphan Drug Designation for Tesomet in Prader-Willi Syndrome
03 Mar 2021 12:00 GMT
… drug designation is a special status granted by the FDA to medicines … -controlled Phase 2a trial in adults and … trials. Saniona is also evaluating Tesomet for the treatment of hypothalamic obesity … dose combination therapy of tesofensine (a triple monoamine …
-
Saniona Reports Positive Topline Results from Tesomet Phase 2 Open-Label Extension Study in Hypothalamic Obesity
23 Nov 2020 16:00 GMT
… of the trial. “Hypothalamic obesity is a … DMSc., Department of Medical Endocrinology and Metabolism, Rigshospitalet … combination therapy of tesofensine (a triple monoamine … this treatment globally. About Hypothalamic Obesity (HO)
Hypothalamic obesity (HO …
-
New obesity pill assures two-fold weight loss
19 Jul 2020 08:48 GMT
… obesity treatments currently in the marketed, the tests of the novel drug … day-diet pill, as part of the Phase II trial of Tesofensine, … -obesity drug as it now enters the Phase III trials … our genes, medical and psychiatric illness. Obesity eventually causes us …